U.S. Mulls Registration Fees For Foreign Drug Manufacturers
This article was originally published in PharmAsia News
Executive Summary
In light of recent safety concerns about foreign-manufactured pharmaceutical products, members of the U.S. Congress are considering whether to introduce registration fees for foreign drug manufacturers exporting products to the U.S